Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Jayamas Medica Industri Tbk. (OMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Jayamas Medica Industri Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Jayamas Medica Industri Tbk. trades at Rp226 (market cap 6.33T, 17.41M 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 38.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Jayamas Medica Industri Tbk. is more actively traded (17.41M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | OMED | |
|---|---|---|
Market Cap | 164.65B | 6.33T |
Volume | 62.5K | 17.41M |
Lot | 625 | 174.13K |
Turnover | 15.03M | 3.92B |
Average Price | 240.55 | 225.28 |
Value | 15.03M | 3.92B |
Indicative Equilibrium Price | 238 | 226 |
Indicative Equilibrium Volume | 100 | 51.45K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Jayamas Medica Industri Tbk.
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →
